Related Experiment Video
Updated: Aug 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells
Kerstin Herzer1, Tom M Ganten, Henning Schulze-Bergkamen
1Division of Immunogenetics, German Cancer Research Center, Heidelberg.
Abstract:
Transforming growth factor beta (TGF-beta) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. However, the exact mechanism through which TGF-beta induces cell death is still unknown. We examined a potential role of various death receptor/ligand systems in TGF-beta-induced apoptosis and identified the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a mediator of TGF-beta-induced apoptosis in hepatoma cells. TGF-beta-induced apoptosis is significantly impaired upon blockage of TRAIL. We show that TRAIL is upregulated in hepatoma cells upon treatment with TGF-beta, whereas TRAIL receptor levels remain unchanged. In conclusion, our results provide evidence that the TRAIL system is critically involved in TGF-beta-induced cell death in liver pathology.
Insights
Transforming growth factor beta (TGF-beta) induces apoptosis in liver cells. This study reveals that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates this TGF-beta-induced cell death in hepatoma cells.
Area of Science:
- Hepatology
- Cell Death Research
- Molecular Biology
Background:
- Transforming growth factor beta (TGF-beta) is known to induce apoptosis in hepatocytes.
- The precise molecular mechanisms underlying TGF-beta-mediated apoptosis remain unclear.
Purpose of the Study:
- To investigate the role of death receptor/ligand systems in TGF-beta-induced apoptosis.
- To identify specific mediators of TGF-beta-induced cell death in hepatoma cells.
Main Methods:
- Examined various death receptor/ligand systems.
- Utilized hepatoma cell models.
- Assessed the impact of TRAIL blockage on TGF-beta-induced apoptosis.
- Measured TRAIL and TRAIL receptor expression levels.
Main Results:
- Identified tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key mediator.
- TGF-beta treatment upregulated TRAIL expression in hepatoma cells.
- Blocking TRAIL significantly impaired TGF-beta-induced apoptosis.
- TRAIL receptor levels remained unaffected by TGF-beta treatment.
Conclusions:
- The TRAIL system is a critical component of TGF-beta-induced apoptosis in liver cells.
- This finding provides mechanistic insight into TGF-beta's role in liver pathology.
- Targeting the TRAIL pathway may offer therapeutic strategies for liver diseases.
Related Concept Videos
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
